Bonora E - Search Results

1

Gastrointestinal Tolerability of Once-Weekly Dulaglutide 3.0 mg and 4.5 mg: A Post Hoc Analysis of the Incidence and Prevalence of Nausea, Vomiting, and Diarrhea in AWARD-11.

Van J, Frias JP, Bonora E, Raha S, Meyer J, Jung H, Cox D, Konig M, Peleshok J, Bethel MA. Van J, et al. Among authors: bonora e. Diabetes Ther. 2021 Oct;12(10):2783-2794. doi: 10.1007/s13300-021-01140-9. Epub 2021 Sep 12. Diabetes Ther. 2021. PMID: 34514554 Free PMC article.

2

Efficacy and Safety of Dulaglutide 3.0 mg and 4.5 mg Versus Dulaglutide 1.5 mg in Metformin-Treated Patients With Type 2 Diabetes in a Randomized Controlled Trial (AWARD-11).

Frias JP, Bonora E, Nevarez Ruiz L, Li YG, Yu Z, Milicevic Z, Malik R, Bethel MA, Cox DA. Frias JP, et al. Among authors: bonora e. Diabetes Care. 2021 Mar;44(3):765-773. doi: 10.2337/dc20-1473. Epub 2021 Jan 4. Diabetes Care. 2021. PMID: 33397768 Free PMC article. Clinical Trial.

3

Efficacy and safety of dulaglutide 3.0 and 4.5 mg in patients aged younger than 65 and 65 years or older: Post hoc analysis of the AWARD-11 trial.

Frias JP, Bonora E, Nevárez Ruiz L, Hsia SH, Jung H, Raha S, Cox DA, Bethel MA, Konig M. Frias JP, et al. Among authors: bonora e. Diabetes Obes Metab. 2021 Oct;23(10):2279-2288. doi: 10.1111/dom.14469. Epub 2021 Jul 8. Diabetes Obes Metab. 2021. PMID: 34159708 Free PMC article. Clinical Trial.

4

Effect of dulaglutide 3.0 and 4.5 mg on weight in patients with type 2 diabetes: Exploratory analyses of AWARD-11.

Bonora E, Frias JP, Tinahones FJ, Van J, Malik RE, Yu Z, Mody R, Bethel A, Kwan AYM, Cox DA. Bonora E, et al. Diabetes Obes Metab. 2021 Oct;23(10):2242-2250. doi: 10.1111/dom.14465. Epub 2021 Jun 29. Diabetes Obes Metab. 2021. PMID: 34189841 Free PMC article. Clinical Trial.

5

Glycaemic efficacy of an expanded dose range of dulaglutide according to baseline glycated haemoglobin (HbA1c) subgroup: Post hoc analysis of AWARD-11.

Frias JP, Bonora E, Cox DA, Bethel MA, Kwan AYM, Raha S, Malik RE. Frias JP, et al. Among authors: bonora e. Diabetes Obes Metab. 2021 Dec;23(12):2819-2824. doi: 10.1111/dom.14533. Epub 2021 Sep 14. Diabetes Obes Metab. 2021. PMID: 34463420 Free PMC article. Clinical Trial.

6

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes.

Bakris GL, Agarwal R, Anker SD, Pitt B, Ruilope LM, Rossing P, Kolkhof P, Nowack C, Schloemer P, Joseph A, Filippatos G; FIDELIO-DKD Investigators. Bakris GL, et al. N Engl J Med. 2020 Dec 3;383(23):2219-2229. doi: 10.1056/NEJMoa2025845. Epub 2020 Oct 23. N Engl J Med. 2020. PMID: 33264825 Free article. Clinical Trial.

7

Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes.

Pitt B, Filippatos G, Agarwal R, Anker SD, Bakris GL, Rossing P, Joseph A, Kolkhof P, Nowack C, Schloemer P, Ruilope LM; FIGARO-DKD Investigators. Pitt B, et al. N Engl J Med. 2021 Dec 9;385(24):2252-2263. doi: 10.1056/NEJMoa2110956. Epub 2021 Aug 28. N Engl J Med. 2021. PMID: 34449181 Clinical Trial.

8

Metabolic effects of aerobic training and resistance training in type 2 diabetic subjects: a randomized controlled trial (the RAED2 study).

Bacchi E, Negri C, Zanolin ME, Milanese C, Faccioli N, Trombetta M, Zoppini G, Cevese A, Bonadonna RC, Schena F, Bonora E, Lanza M, Moghetti P. Bacchi E, et al. Among authors: bonora e. Diabetes Care. 2012 Apr;35(4):676-82. doi: 10.2337/dc11-1655. Epub 2012 Feb 16. Diabetes Care. 2012. PMID: 22344613 Free PMC article. Clinical Trial.

9

Design and Baseline Characteristics of the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease Trial.

Ruilope LM, Agarwal R, Anker SD, Bakris GL, Filippatos G, Nowack C, Kolkhof P, Joseph A, Mentenich N, Pitt B; FIGARO-DKD study investigators. Ruilope LM, et al. Am J Nephrol. 2019;50(5):345-356. doi: 10.1159/000503712. Epub 2019 Oct 30. Am J Nephrol. 2019. PMID: 31665733 Free PMC article. Clinical Trial.

10

Glomerular filtration rate decline in T2DM following diagnosis. The Verona newly diagnosed diabetes study-12.

Zoppini G, Trombetta M, Pastore I, Brangani C, Cacciatori V, Negri C, Perrone F, Pichiri I, Stoico V, Travia D, Rinaldi E, Da Prato G, Bittante C, Bonadonna RC, Bonora E. Zoppini G, et al. Among authors: bonora e. Diabetes Res Clin Pract. 2021 May;175:108778. doi: 10.1016/j.diabres.2021.108778. Epub 2021 Mar 22. Diabetes Res Clin Pract. 2021. PMID: 33766697

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

496 results

Search Page

Filters